INVEX Therapeutics Ltd (IXC) - Total Liabilities

Latest as of December 2025: AU$176.49K AUD ≈ $124.88K USD

Based on the latest financial reports, INVEX Therapeutics Ltd (IXC) has total liabilities worth AU$176.49K AUD (≈ $124.88K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore INVEX Therapeutics Ltd (IXC) equity growth momentum to track the company's year-over-year net asset growth rate.

INVEX Therapeutics Ltd - Total Liabilities Trend (2019–2025)

This chart illustrates how INVEX Therapeutics Ltd's total liabilities have evolved over time, based on quarterly financial data.

INVEX Therapeutics Ltd Competitors by Total Liabilities

The table below lists competitors of INVEX Therapeutics Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Flour Mills C. Sarantopoulos S.A. AT:KYSA	Greece	€29.31 Million
PT Sunter Lakeside Hotel Tbk JK:SNLK	Indonesia	Rp42.71 Billion
Adroit Infotech Limited NSE:ADROITINFO	India	Rs275.75 Million
Pila Pharma AB ST:PILA	Sweden	Skr1.43 Million
Dynasty Gold Corp V:DYG	Canada	CA$542.41K
Gratifii Ltd AU:GTI	Australia	AU$16.47 Million
Warehouse REIT plc LSE:WHR	UK	GBX300.12 Million
Surya Biru Murni Acetylene Tbk PT JK:SBMA	Indonesia	Rp53.27 Billion

Liability Composition Analysis (2019–2025)

This chart breaks down INVEX Therapeutics Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see INVEX Therapeutics Ltd market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	26.76	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.04	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.04	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how INVEX Therapeutics Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for INVEX Therapeutics Ltd (2019–2025)

The table below shows the annual total liabilities of INVEX Therapeutics Ltd from 2019 to 2025.

Year	Total Liabilities	Change
2025-06-30	AU$220.59K ≈ $156.08K	-48.89%
2024-06-30	AU$431.63K ≈ $305.41K	-72.55%
2023-06-30	AU$1.57 Million ≈ $1.11 Million	+56.58%
2022-06-30	AU$1.00 Million ≈ $710.55K	+52.47%
2021-06-30	AU$658.61K ≈ $466.01K	-67.32%
2020-06-30	AU$2.02 Million ≈ $1.43 Million	+115.43%
2019-06-30	AU$935.49K ≈ $661.92K	--

About INVEX Therapeutics Ltd

AU:IXC Australia Biotechnology

Market Cap

$5.85 Million

AU$8.27 Million AUD

Market Cap Rank

#28263 Global

#1469 in Australia

Share Price

AU$0.11

Change (1 day)

+0.00%

52-Week Range

AU$0.08 - AU$0.16

All Time High

AU$1.67